<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-QZGCPSZE</identifier><date>2013</date><creator>Filipović, Lana</creator><relation>documents/doc/Q/URN_NBN_SI_doc-QZGCPSZE_001.pdf</relation><relation>documents/doc/Q/URN_NBN_SI_doc-QZGCPSZE_001.txt</relation><format format_type="issue">4</format><format format_type="volume">47</format><format format_type="type">article</format><format format_type="extent">str. 346-357, III</format><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">273510400</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-QZGCPSZE</identifier><language>eng</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">angiogeneza</subject><subject language_type_id="slv">apoptoza</subject><subject language_type_id="eng">cisplatin</subject><subject language_type_id="slv">onkologija</subject><title>Biological evaluation of trans-dichloridoplatinum(II) complexes with 3- and 4-acettylpyridine in comparison to cisplatin</title></Record>